Types segmentation distinguishes the protein sources themselves, separating microalgal from seaweed origins and further subdividing each into extraction formats. Microalgae proteins are principally derived from Spirulina, Chlorella, and Nannochloropsis species; they are marketed as whole‑cell biomass, protein isolates, or enzymatically hydrolyzed peptides. Whole‑cell biomass, accounting for roughly 40 % of microalgal protein sales, offers the lowest processing cost and is favoured in animal‑feed and bulk food applications. Protein isolates, representing about 35 %, command premium pricing for food‑grade purity and are central to functional‑ingredient portfolios. Hydrolysates, at 25 %, provide targeted bioactive profiles for nutraceutical and cosmetic uses. Seaweed proteins originate from red, brown, and green macro‑algae, and are similarly offered as whole‑seaweed flour, alkaline‑extracted isolates, or ultrafiltration‑derived concentrates. Whole‑seaweed flour supplies 45 % of seaweed protein volume, driven by low‑cost feed formulations; isolates contribute 30 % for high‑value food and supplement markets; concentrates hold 25 % for specialized cosmetic actives. This typology clarifies how each protein type underpins distinct revenue streams within the overall market taxonomy.